Nemzeti Influenza Pandémiás Terv

Pandemic Preparedness and Response National Control Plan 2009
Hungary English PDF
National

AI-Generated Document Summary

Objectives

The National Influenza Pandemic Plan establishes a national, phase-based framework for preparedness, containment, response, recovery and post-pandemic review in the event of a novel influenza virus with sustained human-to-human transmission and international spread.It aligns national action with World Health Organization guidance, International Health Regulations (2005) and European Union preparedness arrangements.Its overarching purpose is to reduce transmission, illness, complications and deaths while protecting health workers, sustaining healthcare, essential services, public administration, the economy and wider societal functioning.

  • Reduce epidemic spread, morbidity and mortality through prevention, vaccination, antiviral medicines, infection control, surveillance and proportionate public-health measures.
  • Maintain continuity of essential health services, including primary care, emergency transport, inpatient care, intensive care, diagnostics and treatment for severe cases, while deferring non-urgent activity when demand exceeds capacity.
  • Protect vulnerable populations, healthcare workers, people exposed to animal-origin influenza and groups essential to the continuity of economic and public functions.
  • Secure conditions for mass vaccination, including accelerated vaccine authorisation, prioritisation, procurement, distribution and vaccination of priority groups when a pandemic-specific vaccine becomes available.
  • Maintain essential national functions and critical infrastructure, including energy, water, transport, food supply, banking, communications, public safety, defence and public administration.
  • Strengthen public and professional communication to promote hygiene, preventive behaviour, reliable information use, participation in response measures and avoidance of panic.
  • Restore inter-pandemic health-system operations, replenish reserves, address postponed and pandemic-related care, assess the first wave and prepare for possible subsequent waves.

Implementation

Implementation follows World Health Organization pandemic phases, from inter-pandemic preparedness through alert, containment, sustained transmission, post-peak recovery and post-pandemic evaluation.It uses a whole-of-society and whole-of-government model in which the Government leads cross-sector coordination, health authorities direct technical and operational measures, and businesses, civil society, families and individuals support continuity and protective action.

  • Coordinate national leadership through the Government, the Governmental Coordination Committee and its Operational Staff, the Epidemic Defence Working Group and other pandemic coordination bodies, with the Ministry of Health and National Chief Medical Officer holding central health responsibilities.
  • Engage public-health institutions, including the National Public Health and Medical Officer Service, National Public Health Centre, National Centre for Epidemiology, National Ambulance Service, regional and sub-regional institutes, health providers and patient-transport services.
  • Align sectoral, regional, institutional, hospital and business-continuity plans with the national plan; require their regular review, testing and revision.
  • Conduct seasonal, epidemiological and virological surveillance; investigate clusters, animal-origin infections and unexplained respiratory illness; test samples, characterise circulating viruses and assess antiviral resistance where necessary.
  • Report new-virus infections and other relevant public-health threats through World Health Organization and European Union mechanisms, including the national International Health Regulations Information Centre and the Early Warning and Response System.
  • Escalate response measures according to national and international epidemiological conditions, including rapid case investigation, laboratory confirmation, contact tracing, isolation, local outbreak suppression, travel-related measures and reinforced surveillance.
  • Expand healthcare surge capacity through additional infectious-disease beds, temporary re-profiling, emergency hospitals, workforce redeployment, volunteer mobilisation, discharge of suitable chronic-care patients and prioritisation of severe or time-critical care.
  • Maintain medicines, diagnostics, personal protective equipment, vaccines and State Health Reserve supplies through stock assessment, procurement, storage, distribution and monitoring arrangements.
  • Communicate through coordinated risk and crisis communication using official websites, media, professional networks, telephone services, civil society partners and international contact points.
  • Review preparedness at least annually, including through the Pandemic Protection Working Group, and use World Health Organization and European Centre for Disease Prevention and Control guidance and indicators to amend the plan where needed.
  • Evaluate interventions, vaccination and antiviral use for effectiveness, safety, acceptability and, after the pandemic, cost-effectiveness; report lessons and revise plans accordingly.

Monitoring & Evaluation

The plan establishes a phase-based monitoring, surveillance and review system that combines epidemiological and virological intelligence, operational reporting, plan testing and post-event evaluation. It assigns oversight across national health authorities, government coordination bodies, regional services and international reporting networks, but does not provide a single consolidated indicator framework or independent audit mechanism.

  • Use World Health Organization phase definitions, sustained transmission patterns, geographical spread, post-peak decline and return to seasonal baseline to assess pandemic progression and trigger phase-appropriate measures.
  • Operate seasonal influenza surveillance through the National Centre for Epidemiology, regional and sub-regional public-health institutes and designated general practitioners, covering approximately 20% of the population from epidemiological week 40 to week 20 of the following year.
  • Analyse influenza-like illness by frequency and location, investigate unexplained respiratory clusters and deaths, identify animal-origin infections, trace transmission routes, and test respiratory samples for circulating variants and antiviral resistance where necessary.
  • Publish influenza situation updates every Wednesday during the surveillance period and report national data through the European Influenza Surveillance Scheme and the World Health Organization Global Influenza Surveillance Network.
  • Report human infections caused by a new influenza virus to the World Health Organization through the national International Health Regulations Information Centre, and report relevant threats to the European Union Early Warning and Response System through designated national contact points.
  • Review national epidemiological conditions and preparedness at least twice yearly through the Epidemiological Defence Working Committee, assess readiness and priority plans, and report annually on preparedness to the National Defence Committee.
  • Test and evaluate pandemic plans, harmonise national, sectoral, organisational, regional and hospital plans, and require institutions to update plans periodically under regional chief medical officer oversight.
  • Collect detailed epidemiological, clinical and virological data on the first 100 cases during pandemic emergence, maintain a central database at the National Centre for Epidemiology, and notify the World Health Organization and European Union.
  • Increase virological sampling by at least 50% in influenza sentinel surveillance across age groups and regions when novel-virus detection requires strengthened surveillance.
  • Monitor hospitalisations, deaths, school and workplace absence, continuity of essential services and critical infrastructure, workforce availability, hospital capacity, vaccine and antiviral stocks, and impacts on heavily affected social groups.
  • Assess intervention effectiveness, safety, acceptability, efficiency and, where data permit, antiviral and vaccine effectiveness, antibiotic sensitivity in bacterial complications and actual antiviral consumption against planned use.
  • Review the effectiveness, appropriateness and cost-effectiveness of preparedness and response measures after the pandemic, require institutional reviews within one month of the outbreak ending, and submit a summary assessment to the health minister and Government.
  • Review the pandemic plan and national preparedness at least annually, using European Centre for Disease Prevention and Control and World Health Organization guidance and indicators, and communicate publicly on the effectiveness of measures.

Costing & Financing

The plan recognises that pandemic preparedness and response require advance costing, budgetary support, reserve management, vaccine and medicine financing, and rapid mobilisation of domestic and international resources. It identifies substantial economic and service-disruption risks, but provides no quantified budget, unit costs, funding gap, financing allocation or macroeconomic assumption.

  • Make foreseeable the costs of pandemic prevention and control, including the associated requirement for budgetary support.
  • Prepare preliminary estimates for financing vaccines and medicines needed during a pandemic, based on readiness assessments and priority plans.
  • Seek additional Government budgetary resources for preparedness when required.
  • Prepare a cost plan for pandemic-plan measures falling under the responsibility of the National Public Health and Medical Officer Service, while the health minister seeks further resources from Government.
  • Review State Health Reserve stocks of antivirals, medicines, medical materials and equipment, and mobilise domestic supplies, staff and additional resources during an outbreak.
  • Seek Government financial cover for production and state procurement of a novel pandemic vaccine, in line with World Health Organization recommendations.
  • Ensure financial and legal conditions for the seasonal influenza vaccination strategy, including programme funding, contracting, procurement, storage, logistics and coverage monitoring.
  • Estimate personal protective equipment quantities, distribution arrangements and cost plans, and assess requirements for antivirals, other medicines, diagnostic supplies, laboratory reagents, hospital beds and workforce continuity.
  • Use the State Health Reserve, subject to Government approval, to support hospitals with emergency treatment facilities, equipment, health materials and medicines.
  • Recognise potential economic consequences including workforce absenteeism, reduced gross domestic product, disruption to essential services, and increased treatment, prevention and sickness-benefit costs.
  • Seek Government reimbursement after the pandemic for uncompensated additional response costs and replenishment of supplies issued from the State Health Reserve.

Document Viewer